Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenue:        
Product revenues $ 0 $ 0 $ 0 $ 0
License revenues 0 0 0 0
Total revenue 0 0 0 0
Cost of product revenue 0 0 0 0
Gross profit 0 0 0 0
Operating Expenses:        
Research and development 526,000 250,000 911,000 725,000
Selling, general and administrative expenses 126,330,000 2,280,000 128,768,000 7,827,000
Total operating expenses 126,856,000 2,530,000 129,679,000 8,552,000
Loss from Operations (126,856,000) (2,530,000) (129,679,000) (8,552,000)
Other income (expense)        
Change in value of warrant and derivative liabilities (1,451,000) 436,000 925,000 37,195,000
Interest expense (3,769,000) (1,536,000) (8,467,000) (4,781,000)
Total other income (expense) (5,220,000) (1,100,000) (7,542,000) 32,414,000
Income (loss) before minority interest and provision for income taxes (132,076,000) (3,630,000) (137,221,000) 23,862,000
Plus: net (income) loss attributable to the noncontrolling interest 0 0 0 0
Income (loss) before provision for income taxes (132,076,000) (3,630,000) (137,221,000) 23,862,000
Provision for income taxes 0 0 0 0
Net income (loss) $ (132,076,000) $ (3,630,000) $ (137,221,000) $ 23,862,000
Weighted Average Common Shares Outstanding - Basic 16,027,687 91,540 5,628,529 75,522
Weighted Average Common Shares Outstanding - Diluted 16,027,687 91,540 5,628,529 75,522
Net income (loss) per share - Basic $ (8.24) $ (39.65) $ (24.38) $ 315.96
Net income (loss) per share - Diluted $ (8.24) $ (39.65) $ (24.38) $ 315.96